aKLmRNA-mediated Protein Replacement Therapy
NCT07544420
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Aging
Interventions
DRUG:
aKLmRNA (AKL003)
OTHER:
Placebo
Sponsor
Klothea Bio Inc